← Back to Search

Cannabidiol for Healthy Subjects

Q: Is enrollment still available for participation in this research?

<p>According to clinicaltrials.gov, the most recent update for this trial was on February 7th 2022 and it is not currently accepting new patients. However, 839 other studies are actively looking for participants at this time.</p>

Phase < 1

Waitlist Available

Research Sponsored by Castleton University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 8 days

Awards & highlights

Study Summary

This trial looked at the effects of CBD on autonomic function and exercise performance in older adults.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 8 days

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~8 days

This trial's timeline: 3 weeks for screening, Varies for treatment, and 8 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in heart rate variability (HRV) as assessed by frequency-domain analysis: LF/HF ratio.

Change in heart rate variability (HRV) as assessed by frequency-domain analysis: high-frequency (HF).

Change in heart rate variability (HRV) as assessed by frequency-domain analysis: low-frequency (LF).

+6 more

Secondary outcome measures

Blood pressure

Borg's Category-Ratio Scale for Rating of Perceived Exertion

Other outcome measures

Blood lactate

Breathing frequency

Change in exercise duration

+2 more

Side effects data

From 2022 Phase 2 & 3 trial • 90 Patients • NCT04387617

38%

Tiredness

24%

Drowsiness

24%

Poor sleep

22%

Constipation

18%

Poor Appetite

16%

Dizziness

Headache

Diarrhea

Nausea

Itching

100%

80%

60%

40%

20%

Study treatment Arm

CBD Oil Group

Control Group

Trial Design

4Treatment groups

Experimental Treatment

Placebo Group

Group I: Cannabidiol 50 mgExperimental Treatment1 Intervention

Participants will ingest 3ml of MCT (medium-chain triglycerides) oil containing 50 mg of CBD.

Group II: Cannabidiol 25 mgExperimental Treatment1 Intervention

Participants will ingest 3ml of MCT (medium-chain triglycerides) oil containing 25 mg of CBD.

Group III: Cannabidiol 200 mgExperimental Treatment1 Intervention

Participants will ingest 3ml of MCT (medium-chain triglycerides) oil containing 200 mg of CBD.

Group IV: PlaceboPlacebo Group1 Intervention

Participants will ingest 3ml of non-CBD containing MCT (medium-chain triglycerides) oil.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Cannabidiol

FDA approved

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Castleton UniversityLead Sponsor

1 Previous Clinical Trials

18 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is enrollment still available for participation in this research?

"According to clinicaltrials.gov, the most recent update for this trial was on February 7th 2022 and it is not currently accepting new patients. However, 839 other studies are actively looking for participants at this time."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Cannabidiol Effects on Cardiovascular System and Exercise Responses

Andrea Corcoran 2023. "Cannabidiol Effects on Cardiovascular System and Exercise Responses". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05232123.